China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)
China flag China · Delayed Price · Currency is CNY
13.25
-0.04 (-0.30%)
Nov 17, 2026, 3:04 PM CST

SHE:300294 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-167.93112.7396.99237.47432.2344.53
Depreciation & Amortization
147.98147.98102.9898.5797.0399.35
Other Amortization
16.7616.7613.9815.3913.7413.63
Loss (Gain) From Sale of Assets
-5.1-5.10.61-1.3-0.070.87
Asset Writedown & Restructuring Costs
309.6309.683.8326.7253.6580.57
Loss (Gain) From Sale of Investments
-59.98-59.98-65.58-99.75-43.84-43.11
Provision & Write-off of Bad Debts
21.5121.518.792.372.80.05
Other Operating Activities
156.88-28-16.5914.4613.9231.26
Change in Accounts Receivable
-471.72-471.72-211.4940.02-11.73799.83
Change in Inventory
-12.6-12.6-120.06107.011.2811.77
Change in Accounts Payable
102.14102.14116.59-92.3256.244.14
Change in Unearned Revenue
5.885.88-4.01-3.57-4.13-1.46
Change in Other Net Operating Assets
----3.2811.59
Operating Cash Flow
-34.5961.16299.78641.73596.441,345
Operating Cash Flow Growth
--79.60%-53.29%7.59%-55.67%87.23%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-471.5-535.31-197.79-87.5-138.41-68.12
Sale of Property, Plant & Equipment
6.413.061.823.260.334.41
Cash Acquisitions
---1,778---
Divestitures
62.02193.79239.61269--
Investment in Securities
50.26-397.98975.51-248.85-500-2,505
Other Investing Activities
60.955.52111.2678.3377.8632.4
Investing Cash Flow
-291.92-680.91-647.5314.25-560.22-2,536

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-47.04-22.15-251.85
Long-Term Debt Repaid
--5.87-76.3-24.98-3.82-563.55
Lease Payments
-5.87-5.87-2.31-2.83-3.82-3.85
Net Debt Issued (Repaid)
51.2341.17-76.3-2.83-3.82-311.7
Issuance of Common Stock
-----2,400
Common Dividends Paid
-37.16-156.4-232.41-100.85-83.19-46.03
Other Financing Activities
-6.69-39.845.24-132.972-9.64
Financing Cash Flow
7.38-155.07-303.47-236.65-85.012,032

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.36-0.13----
Net Cash Flow
-319.48-774.96-651.23419.33-48.79841.39

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-506.09-474.15101.99554.23458.031,277
Free Cash Flow Growth
---81.60%21.00%-64.14%121.72%
Free Cash Flow Margin
-35.34%-23.03%5.88%20.90%16.60%48.19%
Free Cash Flow Per Share
-0.97-0.930.201.100.912.93
Levered Free Cash Flow
-685.68-361.3216.4376.4354.851,141
Unlevered Free Cash Flow
-684.2-360.616.82376.68355.241,148
Free Cash Flow After Leases
-511.96-480.0199.68551.4454.211,273

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
124.33183.18167.06250.39227.94192.85
Change in Working Capital
-454.32-454.32-225.247.7927.01818.22